Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
P. R. health sci. j ; 24(1): 27-33, mar. 2005.
Article in English | LILACS | ID: lil-406523

ABSTRACT

The post-genomics scientific era has evolved rapidly while achieving advanced understanding of the structure and function of the genes responsible for both the phenotypic characteristics of higher organisms and the pathophysiology of several genetic diseases. Researchers in the fields of oncology and infectious diseases have become more convinced of the great potential of molecular biology approaches to further develop highly specific diagnostic and less toxic therapeutic strategies. During the last two decades, approaches for the specific silencing of essential viral genes and cellular oncogenes were evaluated with optimism for developing directed therapies. However, there were drawbacks in the use of antisense oligonucleotides as a practical mechanism of achieving gene silencing both in vitro and in vivo. Recently, a novel role for post-transcriptional gene silencing mediated by double-stranded RNA (dsRNA) was discovered in the experimental model of C. elegans. This mechanism, termed RNA interference (RNAi) has also been found in other eukaryotes, from plants to mammals, including humans. RNAi is presently being explored both in vitro and in vivo in functional genomics studies and possible therapeutic uses due to its highly specific and physiologic mode of gene silencing. This article focuses on the most current information available regarding the RNAi mechanism and its uses in models of cancer and infectious diseases.


Subject(s)
Humans , Animals , RNA Interference/physiology , Molecular Biology , Genetic Therapy/methods , Eukaryotic Cells/physiology , Gene Silencing/physiology
2.
Biol. Res ; 38(2/3): 121-146, 2005. ilus
Article in English | LILACS | ID: lil-424717

ABSTRACT

Ribosome recruitment to eukaryotic mRNAs is generally thought to occur by a scanning mechanism, whereby the 40S ribosomal subunit binds in the vicinity of the 5'cap structure of the mRNA and scans until an AUG codon is encountered in an appropriate sequence context. Study of the picornaviruses allowed the characterization of an alternative mechanism of translation initiation. Picornaviruses can initiate translation via an internal ribosome entry segment (IRES), an RNA structure that directly recruits the 40S ribosomal subunits in a cap and 5' end independent fashion. Since its discovery, the notion of IRESs has extended to a number of different virus families and cellular RNAs. This review summarizes features of both cap-dependent and IRES-dependent mechanisms of translation initiation and discusses the role of cis-acting elements, which include the 5'cap, the 5'-untranslated region (UTR) and the poly(A) tail as well as the possible roles of IRESs as part of a cellular stress response mechanism and in the virus replication cycle.


Subject(s)
Humans , Animals , RNA, Messenger/analysis , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Eukaryotic Cells/cytology , Eukaryotic Cells/physiology , Eukaryotic Cells/virology , Eukaryotic Initiation Factors/analysis , Eukaryotic Initiation Factors/biosynthesis , Eukaryotic Initiation Factors/genetics , Proteins , RNA, Ribosomal/analysis , RNA, Ribosomal/biosynthesis , RNA, Ribosomal/chemical synthesis
4.
Arch. argent. pediatr ; 93(4): 270-84, 1995. ilus, tab
Article in Spanish | LILACS | ID: lil-247447

ABSTRACT

El síndrome de disfunción (falla) orgánica múltiple es diagnosticado cada vez con más frecuencia en todo el espectro etario. La sobrevida lograda con los avances en las técnicas de resucitación de shock, sepsis y trauma se ha visto acompañada de una mayor incidencia de esta entidad. A pesar de casi una década de su descripción en niños y de su importancia existen muy pocas publicaciones en pediatría. Inicialmente se pensaba que el síndrome era sinónimo de complicaciones infecciosas y/o trauma. La caracterización de esta enfermedad, la importancia del "huésped" en la fisiopatología y manifestaciones clínicas del síndrome, el cuadro clínico, los principios terapéuticos, la prevención y su pronóstico son analizados en detalle en una revisión extensa de la literatura


Subject(s)
Humans , Male , Infant, Newborn , Child, Preschool , Child , Multiple Organ Failure/diagnosis , Risk Factors , Eukaryotic Cells/physiology , Eukaryotic Cells/pathology , Inflammation/physiopathology , Inflammation Mediators/adverse effects , Multiple Organ Failure/physiopathology , Multiple Organ Failure/prevention & control , Prognosis , Receptors, Interleukin/antagonists & inhibitors , Sepsis/complications , Sepsis/mortality
SELECTION OF CITATIONS
SEARCH DETAIL